ArticleHaemophilia : the official journal of the World Federation of Hemophilia2021

Patient preference for emicizumab versus prior factor therapy in people with haemophilia A: Results from the HAVEN 3 and HAVEN 4 studies.

Aric Parnes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.